Tehran University of Medical Sciences

Science Communicator Platform

Share By
Rifampicin Resistance in Mycobacterium Tuberculosis in Iran: A Two-Centre Study Publisher



Bahraminia F1 ; Zangiabadian M2 ; Nasiri MJ3 ; Fattahi M4 ; Goudarzi M3 ; Ranjbar R5 ; Imani Fooladi AA1
Authors

Source: New Microbes and New Infections Published:2021


Abstract

Multidrug-resistant tuberculosis remains a challenge. In this study, we investigated the incidence of rifampicin (RIF) resistance in Mycobacterium tuberculosis in a large number of pulmonary specimens. A two-center study in Tehran, the capital of Iran, was performed with 6624 pulmonary samples of patients with tuberculosis (TB) who were subjected to detection of RIF-resistant TB by GeneXpert MTB/RIF assay between May 2014 and July 2018. Conventional drug susceptibility testing was performed to confirm the results. Xpert MTB/RIF identified a total of 96 positives for M. tuberculosis, of which 5 (5.3%) samples were found to be RIF-resistant TB. All RIF-resistant and sensitive isolates detected by GeneXpert were phenotypically confirmed by drug susceptibility testing. These results indicated that the Xpert MTB/RIF test can be used as a rapid diagnostic method and can potentially decrease the morbidity associated with diagnostic delay and mistreatment. © 2021 The Authors
Related Docs
View other Related Docs
1. Drug Resistance Pattern of Mycobacterium Tuberculosis in the Province With Highest Incidence of Tuberculosis in Iran, International Journal of Mycobacteriology (2016)
2. An 8-Year Study on the Prevalence and Drug Resistance of Mycobacteria in Clinical Specimens (2011–2018), Clinical Epidemiology and Global Health (2020)
3. Pattern of Drug Resistant Mycobacterium Tuberculosis in the West and Northwest of Iran: A Meta-Analysis, Iranian Journal of Microbiology (2022)
Experts (# of related papers)
View all Related Experts
Mohammad Mehdi Feizabadi (4)
Leyla Sahebi (2)
Other Related Docs
4. Identification of Mycobacterium Tuberculosis in Pulmonary and Extrapulmonary Specimens of Iranian Hospitalized Patients During 2017-2021, International Journal of Mycobacteriology (2023)
5. Expression Analysis of 10 Efflux Pump Genes in Multidrug-Resistant and Extensively Drug-Resistant Mycobacterium Tuberculosis Clinical Isolates, Journal of Global Antimicrobial Resistance (2019)
6. Molecular Identification of Mutations Conferring Resistance to Rifampin, Isoniazid and Pyrazinamide Among Mycobacterium Tuberculosis Isolates From Iran, Journal of Chemotherapy (2020)
7. Bedaquiline: Current Status and Future Perspectives, Journal of Global Antimicrobial Resistance (2021)
8. Drug Susceptibility Testing of Mycobacterium Simiae: An Emerging Pathogen in Iran, Infectious Disorders - Drug Targets (2021)
9. Rapid Identification of Mycobacterium Species Isolated From Clinical Specimens of City Jahrom by Real Time Pcr, Gene Reports (2020)
10. Differential Gene Expression of Asun, Nemf, Ptprc and Dhx29: Candidate Biomarkers for the Diagnosis of Active and Latent Tuberculosis, Infectious Disorders - Drug Targets (2021)
11. Tuberculosis Comorbidity With Rheumatoid Arthritis: Gene Signatures, Associated Biomarkers, and Screening, IUBMB Life (2021)
12. Resistance of Mycobacterium Tuberculosis Strains to Rifampicin: A Systematic Review and Meta-Analysis, Heliyon (2019)
13. Genotyping and Drug Susceptibility Patterns of M. Tuberculosis Isolated From Hiv Seropositive Patients in Tehran Iran, Current HIV Research (2021)
14. Does the Bcg Vaccine Have Different Effects on Strains of Tuberculosis?, Clinical and Experimental Immunology (2021)
15. Direct Drug Susceptibility Testing of Mycobacterium Tuberculosis Using the Proportional Method: A Multicenter Study, Journal of Global Antimicrobial Resistance (2019)
16. High-Resolution Melt Curve Analysis for Rapid Detection of Rifampicin Resistance in Mycobacterium Tuberculosis: A Single-Centre Study in Iran, New Microbes and New Infections (2020)
17. Low Diagnostic Accuracy of Xpert Mtb/Rif Assay for Extrapulmonary Tuberculosis: A Multicenter Surveillance, Scientific Reports (2019)
18. The Reliability of Rifampicin Resistance As a Proxy for Multidrug-Resistant Tuberculosis: A Systematic Review of Studies From Iran, European Journal of Clinical Microbiology and Infectious Diseases (2018)
19. Rifampicin-Resistant Tuberculosis in Iran: A Systematic Review and Meta-Analysis, Iranian Journal of Basic Medical Sciences (2021)
20. Molecular Detection of Rifampin, Isoniazid, and Ofloxacin Resistance in Iranian Isolates of Mycobacterium Tuberculosis by High-Resolution Melting Analysis, Infection and Drug Resistance (2018)